Verwandte Artikel zu Advances in Surgical and Medical Interventions for...

Advances in Surgical and Medical Interventions for Recalcitrant Chronic Rhinosinusitis - Hardcover

 
9783031891908: Advances in Surgical and Medical Interventions for Recalcitrant Chronic Rhinosinusitis

Inhaltsangabe

This book will aim to educate practicing otolaryngologists and trainees in the diverse spectrum of surgical and medical interventions available for recalcitrant CRS, with an emphasis on novel therapeutic modalities. Chronic rhinosinusitis (CRS) represents one of the most common healthcare problems in the United States (US), with 1 in 6 adults affected and 31 million individuals newly diagnosed each year. Over 22 billion dollars are spent annually in US health care expenditures due to the cost of prescription medications, surgical interventions, and loss of productivity. Management of CRS recalcitrant to standard medical and surgical intervention continues to present a challenge for many otolaryngologists. An overall productivity cost of $10000/per patient per year is estimated for those with such refractory CRS. The last decade has seen significant expansion in our treatment armamentarium for such recalcitrant disease. New surgical approaches, minimally invasive techniques, endoscopic instrumentation, technologic innovations, in-office procedures, etc. have been developed. Systemic immunomodulatory biologics and a vast array of topical agents have also been introduced. These novel therapeutic options have been the topic of numerous panel presentations at educational conferences/courses by the co-editors but no textbook to date has been published focusing on this important subject. Chapters addressing operative and clinic procedures will offer accompanying videos depicting surgical techniques in addition to illustrations and step-by-step descriptions. Sections reviewing new technology and medical therapies will also include tables and reviews of the pertinent literature.

 

Advances in Surgical and Medical Interventions for Recalcitrant Chronic Rhinosinusitis will serve otolaryngologists and trainees in the most up-to-date techniques both surgical and otherwise to address this pervasive issue. It describes new surgical approaches and recent technologic innovations for management of recalcitrant chronic rhinosinusitis, discuss novel medical therapies including nascent systemic biotherapeutics, immunomodulators, and topical additives to assess their potential role in the treatment of refractory chronic rhinosinusitis, and assist practitioners in understanding the relevant evidence, outcomes, and proper application of each therapeutic modality in patients with recalcitrant chronic rhinosinusitis.

Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.

Über die Autorin bzw. den Autor

Jivianne T. Lee, MD FACS

Professor

Rhinology & Endoscopic Skull Base Surgery

Department of Head & Neck Surgery

University of California Los Angeles David Geffen School of Medicine

 

​Peter Hwang, MD

Stanford University

 

Joseph K.  Han, MD

East Virginia Medical School

 

Jakob L. Fischer, MD

Rhinology and Endoscopic Skull Base Surgery

UCLA Department of Head and Neck Surgery

Los Angeles, California, USA

 

Scott Stringer, MD

Virginia Commonwealth University School of Medicine

Otolaryngology-Head and Neck Surgery

Von der hinteren Coverseite

This book educates practicing otolaryngologists and trainees in the diverse spectrum of surgical and medical interventions available for recalcitrant CRS, with an emphasis on novel therapeutic modalities. Chronic rhinosinusitis (CRS) represents one of the most common healthcare problems in the United States (US), with 1 in 6 adults affected and 31 million individuals newly diagnosed each year. Over 22 billion dollars are spent annually in US health care expenditures due to the cost of prescription medications, surgical interventions, and loss of productivity. Management of CRS recalcitrant to standard medical and surgical intervention continues to present a challenge for many otolaryngologists. An overall productivity cost of $10000/per patient per year is estimated for those with such refractory CRS. The last decade has seen significant expansion in treatment armamentarium for such recalcitrant disease. Systemic immunomodulatory biologics and a vast array of topical agents have also been introduced.

Advances in Surgical and Medical Interventions for Recalcitrant Chronic Rhinosinusitis serves otolaryngologists and trainees in the most up-to-date techniques both surgical and otherwise to address this pervasive issue. It describes new surgical approaches and recent technologic innovations for management of recalcitrant chronic rhinosinusitis, discusses novel medical therapies including nascent systemic biotherapeutics, immunomodulators, and topical additives to assess their potential role in the treatment of refractory chronic rhinosinusitis, and assists practitioners in understanding the relevant evidence, outcomes, and proper application of each therapeutic modality in patients with recalcitrant chronic rhinosinusitis. Chapters addressing operative and clinic procedures will offer accompanying videos depicting surgical techniques in addition to illustrations and step-by-step descriptions.

„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.